Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease

被引:172
作者
Chang, Yoosoo
Ryu, Seungho
Sung, Eunju
Jang, Yumi
机构
[1] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Hlth Screening Ctr, Seoul 110746, South Korea
[2] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat Med, Seoul 110746, South Korea
[3] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Family Med, Seoul 110746, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Ulsan, South Korea
关键词
D O I
10.1373/clinchem.2006.081257
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: In nonalcoholic fatty liver disease (NAFLD), increased alanine aminotransferase (ALT) concentrations are considered to be a consequence of hepatocyte damage. We performed a prospective study to examine the association between ALT within its reference interval and risk for subsequent development of NAFLD. Methods: The study cohort comprised 5237 healthy men without diagnosed NAFLD and without increases of either ALT (>= 35 U/L) or gamma-glutamyltransferase (GGT; >= 40 U/L) above the reference intervals. We assessed alcohol intake via self-reporting (questionnaire) and performed biochemical tests for liver and metabolic function and abdominal ultrasonography. We used the Cox proportional hazards model to calculate the adjusted hazard ratios (aHRs) in the model for NAFLD. Results: During 13 276.6 person-years of follow-up over a 4-year period, 984 new incident cases of NAFLD developed. We adjusted for age, weight change, body mass index, glucose, blood pressure, triglycerides, HDL cholesterol, smoking, alcohol consumption, regular exercise, homeostasis model assessment of insulin resistance, C-reactive protein, and incident diabetes. Compared with an ALT concentration of < 16 U/L, aHR values (95% confidence intervals) for ALT concentrations were 1.53 (1.18-1.98), 1.66 (1.29-2.13), 1.62 (1.26-2.08), and 2.21 (1.73-2.81) for ALT concentrations of 16-18, 19-21, 22-25, and 26-34 U/L, respectively. This relationship remained significant even among normal-weight participants who were still within the reference interval of ALT and GGT at all follow-up examinations. Conclusions: In apparently healthy, nondiabetic Korean men, increased ALT concentration, even within the reference interval, was an independent predictor of incident NAFLD. (c) 2007 American Association for Clinical Chemistry.
引用
收藏
页码:686 / 692
页数:7
相关论文
共 31 条
  • [1] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [2] Alanine aminotransferase levels and fatty liver in childhood obesity: Associations with insulin resistance, adiponectin, and visceral fat
    Burgert, Tania S.
    Taksali, Sara E.
    Dziura, James
    Goodman, T. Robin
    Yeckel, Catherine W.
    Papademetris, Xenophon
    Constable, R. Todd
    Weiss, Ram
    Tamborlane, William V.
    Savoye, Mary
    Seyal, Aisha A.
    Caprio, Sonia
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) : 4287 - 4294
  • [3] Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited
    Ceriello, A
    Motz, E
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : 816 - 823
  • [4] Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]
  • [5] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [6] Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients
    Daniel, S
    Ben-Menachem, T
    Vasudevan, G
    Ma, CK
    Blumenkehl, M
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (10) : 3010 - 3014
  • [7] The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
    Hamaguchi, M
    Kojima, T
    Takeda, N
    Nakagawa, T
    Taniguchi, H
    Fujii, K
    Omatsu, T
    Nakajima, T
    Sarui, H
    Shimazaki, M
    Kato, T
    Okuda, J
    Ida, K
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (10) : 722 - 728
  • [8] COMPARISON OF LIVER HISTOLOGY WITH ULTRASONOGRAPHY IN ASSESSING DIFFUSE PARENCHYMAL LIVER-DISEASE
    JOSEPH, AEA
    SAVERYMUTTU, SH
    ALSAM, S
    COOK, MG
    MAXWELL, JD
    [J]. CLINICAL RADIOLOGY, 1991, 43 (01) : 26 - 31
  • [9] Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
    Kim, HC
    Nam, CM
    Jee, SH
    Han, KH
    Oh, DK
    Suh, I
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7446): : 983 - 986C
  • [10] Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background
    Kojima, S
    Watanabe, N
    Numata, M
    Ogawa, T
    Matsuzaki, S
    [J]. JOURNAL OF GASTROENTEROLOGY, 2003, 38 (10) : 954 - 961